Version 5.4
Homo sapiens Protein: NIPA2
Summary
InnateDB Protein IDBP-583125.2
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol NIPA2
Protein Name non imprinted in Prader-Willi/Angelman syndrome 2
Synonyms
Species Homo sapiens
Ensembl Protein ENSP00000437746
InnateDB Gene IDBG-3989 (NIPA2)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 1 experimentally validated interaction(s) in this database.
They are also associated with 1 interaction(s) predicted by orthology.
Experimentally validated
Total 1 [view]
Protein-Protein 1 [view]
Protein-DNA 0
Protein-RNA 0
DNA-DNA 0
RNA-RNA 0
DNA-RNA 0
Predicted by orthology
Total 1 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0015095 magnesium ion transmembrane transporter activity
Biological Process
GO:0015693 magnesium ion transport
Cellular Component
GO:0005769 early endosome
GO:0005886 plasma membrane
GO:0016020 membrane
GO:0016021 integral component of membrane
Protein Structure and Domains
PDB ID
InterPro IPR000620 Drug/metabolite transporter
IPR008521 Magnesium transporter NIPA
PFAM PF00892
PF05653
PRINTS
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt Q8N8Q9
PhosphoSite PhosphoSite-Q8N8Q9
TrEMBL
UniProt Splice Variant
Entrez Gene 81614
UniGene
RefSeq NP_001008894
HUGO HGNC:17044
OMIM 608146
CCDS CCDS73694
HPRD 16290
IMGT
EMBL AC011767 AK096305 AK300843 AY732242 BC000957 BC011775 BK001120 CR606982
GenPept AAH00957 AAH11775 AAU34000 BAC04757 BAG62494 DAA01509

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca